Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,394 | 230 | 97.1% |
| Education | $102.83 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $434.02 | 27 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $370.46 | 36 | $0 (2021) |
| PFIZER INC. | $293.85 | 22 | $0 (2021) |
| Novo Nordisk Inc | $249.49 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $247.99 | 16 | $0 (2020) |
| Lilly USA, LLC | $243.29 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $237.18 | 15 | $0 (2021) |
| ABBVIE INC. | $192.59 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $135.96 | 5 | $0 (2019) |
| Amgen Inc. | $130.01 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.11 | 8 | Lilly USA, LLC ($46.44) |
| 2023 | $173.93 | 6 | InSightec,Inc ($106.18) |
| 2022 | $41.65 | 3 | ABBVIE INC. ($27.84) |
| 2021 | $186.61 | 10 | Lilly USA, LLC ($40.82) |
| 2020 | $250.72 | 15 | GlaxoSmithKline, LLC. ($52.33) |
| 2019 | $759.25 | 51 | AstraZeneca Pharmaceuticals LP ($136.85) |
| 2018 | $878.03 | 67 | Merck Sharp & Dohme Corporation ($128.24) |
| 2017 | $1,067 | 73 | AstraZeneca Pharmaceuticals LP ($140.75) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Medical Device | ||||||
| 06/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes Care | ||||||
| 06/18/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Diabetes | ||||||
| 05/31/2023 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $65.57 | General |
| Category: Neurology | ||||||
| 05/31/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 05/24/2023 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $40.61 | General |
| Category: Neurology | ||||||
| 05/17/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Education | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes Care | ||||||
| 02/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Education | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: VACCINES | ||||||
| 07/28/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Diabetes Care | ||||||
| 05/21/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: VACCINE | ||||||
| 04/23/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Diabetes | ||||||
| 04/16/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Neuroscience | ||||||
| 04/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: DIABETES | ||||||
| 04/09/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: PRIMARY CARE | ||||||
| 03/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 4,119 | 6,111 | $584,776 | $221,357 |
| 2022 | 32 | 3,680 | 5,594 | $473,926 | $178,636 |
| 2021 | 34 | 4,176 | 5,782 | $464,741 | $169,485 |
| 2020 | 35 | 3,770 | 5,184 | $412,758 | $140,006 |
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 428 | 880 | $220,880 | $75,982 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 350 | 350 | $70,000 | $45,213 | 64.6% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 62 | 220 | $28,160 | $11,722 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 179 | $30,251 | $10,987 | 36.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 119 | 120 | $21,000 | $8,628 | 41.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 375 | 600 | $28,800 | $7,844 | 27.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 378 | 615 | $23,370 | $6,347 | 27.2% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 62 | 70 | $17,780 | $6,298 | 35.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $11,390 | $4,799 | 42.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 362 | 574 | $16,072 | $4,358 | 27.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 171 | 240 | $14,400 | $3,942 | 27.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 121 | 122 | $4,880 | $3,678 | 75.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 30 | $10,140 | $3,620 | 35.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 82 | 109 | $11,554 | $3,162 | 27.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 15 | $8,505 | $3,132 | 36.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 177 | 302 | $10,570 | $2,867 | 27.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $5,628 | $2,283 | 40.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 41 | $4,305 | $2,040 | 47.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,025 | $1,820 | 60.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 44 | $3,382 | $1,635 | 48.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 64 | 64 | $4,288 | $1,205 | 28.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 85 | 136 | $7,072 | $1,202 | 17.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 59 | 68 | $3,672 | $1,005 | 27.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 85 | 141 | $2,961 | $793.06 | 26.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 232 | 357 | $2,856 | $783.48 | 27.4% |
About Dr. Christopher Ciccone, M.D
Dr. Christopher Ciccone, M.D is a Family Medicine healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659377356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Ciccone, M.D has received a total of $3,497 in payments from pharmaceutical and medical device companies, with $139.11 received in 2024. These payments were reported across 233 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,394).
As a Medicare-enrolled provider, Ciccone has provided services to 15,745 Medicare beneficiaries, totaling 22,671 services with total Medicare billing of $709,482. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsburg, VA
- Active Since 06/27/2005
- Last Updated 03/24/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1659377356
Products in Payments
- FARXIGA (Drug) $256.65
- JANUVIA (Drug) $253.62
- JARDIANCE (Drug) $253.17
- XARELTO (Drug) $188.64
- Ozempic (Drug) $123.45
- ELIQUIS (Drug) $113.26
- SYMBICORT (Drug) $112.19
- Exablate (Device) $106.18
- TRULICITY (Drug) $103.71
- XIFAXAN (Drug) $88.05
- BELSOMRA (Drug) $74.68
- PREVNAR - 13 (Biological) $72.90
- VRAYLAR (Drug) $66.38
- BEVESPI AEROSPHERE (Drug) $65.18
- Prolia (Biological) $63.87
- TOUJEO (Drug) $61.46
- EMGALITY (Drug) $60.38
- Synthroid (Drug) $59.48
- INVOKANA (Drug) $59.35
- Vascepa (Drug) $56.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsburg
Richard Bagnall, Md, MD
Family Medicine — Payments: $8,648
Bruce Mayer, Md, MD
Family Medicine — Payments: $7,474
Mrs. Monique Sessler, Md, MD
Family Medicine — Payments: $5,642
Elena Viterbo-Noble, Md, MD
Family Medicine — Payments: $5,442
Dr. Jamie Rygielski, D.o, D.O
Family Medicine — Payments: $4,267
Sheba Mohsin, M.d, M.D
Family Medicine — Payments: $3,169